BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32383815)

  • 21. Personalized therapy: CNS HGNET-BCOR responsiveness to arsenic trioxide combined with radiotherapy.
    Paret C; Russo A; Otto H; Mayer A; Zahnreich S; Wagner W; Samuel D; Scharnhorst D; Solomon DA; Dhall G; Wong K; Bender H; Alt F; Wingerter A; Neu MA; Beck O; Prawitt D; Eder S; Henninger N; El Malki K; Lehmann N; Backes N; Roth L; Seidmann L; Sommer C; Brockmann MA; Staatz G; Schmidberger H; Faber J
    Oncotarget; 2017 Dec; 8(69):114210-114225. PubMed ID: 29371980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment response of CNS high-grade neuroepithelial tumors with MN1 alteration.
    Baroni LV; Rugilo C; Lubieniecki F; Sampor C; Freytes C; Nobre L; Hansford JR; Malalasekera VS; Zapotocky M; Dodgshun A; Martinez OC; La Madrid AM; Lavarino C; Suñol M; Rutkowski S; Schuller U; Bouffet E; Ramaswamy V; Alderete D
    Pediatr Blood Cancer; 2020 Dec; 67(12):e28627. PubMed ID: 32959992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging Features with Histopathologic Correlation of CNS High-Grade Neuroepithelial Tumors with a
    Cardoen L; Tauziède-Espariat A; Dangouloff-Ros V; Moalla S; Nicolas N; Roux CJ; Bouchoucha Y; Bourdeaut F; Beccaria K; Bolle S; Pierron G; Dufour C; Doz F; Boddaert N; Brisse HJ
    AJNR Am J Neuroradiol; 2022 Jan; 43(1):151-156. PubMed ID: 34887247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BCOR Internal Tandem Duplication Expression in Neural Stem Cells Promotes Growth, Invasion, and Expression of PRC2 Targets.
    Nakata S; Yuan M; Rubens JA; Kahlert UD; Maciaczyk J; Raabe EH; Eberhart CG
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central Nervous System Tumor With BCL6 Corepressor Internal Tandem Duplication: Treatment Course of a Long-term Survivor.
    Bakkar M; Altinok D; Kupsky WJ; Marupudi NI; Chiang J; Gorsi HS
    J Pediatr Hematol Oncol; 2023 Aug; 45(6):352-355. PubMed ID: 37314948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BCOR Internal Tandem Duplication in High-grade Uterine Sarcomas.
    Mariño-Enriquez A; Lauria A; Przybyl J; Ng TL; Kowalewska M; Debiec-Rychter M; Ganesan R; Sumathi V; George S; McCluggage WG; Nucci MR; Lee CH; Fletcher JA
    Am J Surg Pathol; 2018 Mar; 42(3):335-341. PubMed ID: 29200103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BCOR involvement in cancer.
    Astolfi A; Fiore M; Melchionda F; Indio V; Bertuccio SN; Pession A
    Epigenomics; 2019 May; 11(7):835-855. PubMed ID: 31150281
    [No Abstract]   [Full Text] [Related]  

  • 28. CNS tumor with BCOR internal tandem duplication: Clinicopathologic, molecular characteristics and prognosis factors.
    Wang R; Guan W; Qiao M; Zhang Y; Zhang M; Wang K; Wang Y; Wang L
    Pathol Res Pract; 2022 Aug; 236():153995. PubMed ID: 35809497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pediatric BCOR-Altered Tumors From Soft Tissue/Kidney Display Specific DNA Methylation Profiles.
    Salgado CM; Alaggio R; Ciolfi A; Zin A; Diomedi Camassei F; Pedace L; Milano GM; Serra A; Di Giannatale A; Mastronuzzi A; Gianatti A; Bisogno G; Ferrari A; Tartaglia M; Reyes-Múgica M; Locatelli F; Miele E
    Mod Pathol; 2023 Feb; 36(2):100039. PubMed ID: 36853789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ewing-like sarcomas with BCOR-CCNB3 fusion transcript: a clinical, radiological and pathological retrospective study from the Société Française des Cancers de L'Enfant.
    Cohen-Gogo S; Cellier C; Coindre JM; Mosseri V; Pierron G; Guillemet C; Italiano A; Brugières L; Orbach D; Laurence V; Delattre O; Michon J
    Pediatr Blood Cancer; 2014 Dec; 61(12):2191-8. PubMed ID: 25176412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic analysis demonstrates that histologically-defined astroblastomas are molecularly heterogeneous and that tumors with MN1 rearrangement exhibit the most favorable prognosis.
    Lehman NL; Usubalieva A; Lin T; Allen SJ; Tran QT; Mobley BC; McLendon RE; Schniederjan MJ; Georgescu MM; Couce M; Dulai MS; Raisanen JM; Al Abbadi M; Palmer CA; Hattab EM; Orr BA
    Acta Neuropathol Commun; 2019 Mar; 7(1):42. PubMed ID: 30876455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mutation of BCOR is highly recurrent and oncogenic in mature T-cell lymphoma.
    Kang JH; Lee SH; Lee J; Choi M; Cho J; Kim SJ; Kim WS; Ko YH; Yoo HY
    BMC Cancer; 2021 Jan; 21(1):82. PubMed ID: 33468080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pediatric diffuse glioma with EP300::BCOR fusion manifesting as low-grade epilepsy-associated neuroepithelial tumor: a case presentation.
    Nakata S; Arai Y; Fukuoka K; Shirakura T; Yamazaki A; Osawa S; Hama N; Shibata T; Miyagishima T; Horiguchi K; Tosaka M; Yokoo H; Yoshimoto Y; Nobusawa S
    Brain Tumor Pathol; 2024 Jan; 41(1):35-39. PubMed ID: 38133797
    [No Abstract]   [Full Text] [Related]  

  • 34. Successful Treatment of Recurrent Primitive Myxoid Mesenchymal Tumor of Infancy With
    Cramer SL; Li R; Ali S; Bradley JA; Kim HK; Pressey JG
    J Natl Compr Canc Netw; 2017 Jul; 15(7):868-871. PubMed ID: 28687574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of BCOR gene mutation as a prognostic factor in acute myeloid leukemia with intermediate cytogenetic prognosis.
    Terada K; Yamaguchi H; Ueki T; Usuki K; Kobayashi Y; Tajika K; Gomi S; Kurosawa S; Saito R; Furuta Y; Miyadera K; Tokura T; Marumo A; Omori I; Sakaguchi M; Fujiwara Y; Yui S; Ryotokuji T; Arai K; Kitano T; Wakita S; Fukuda T; Inokuchi K
    Genes Chromosomes Cancer; 2018 Aug; 57(8):401-408. PubMed ID: 29663558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Pan-Cancer Landscape Analysis Reveals a Subset of Endometrial Stromal and Pediatric Tumors Defined by Internal Tandem Duplications of BCOR.
    Juckett LT; Lin DI; Madison R; Ross JS; Schrock AB; Ali S
    Oncology; 2019; 96(2):101-109. PubMed ID: 30380541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gliomatosis cerebri: molecular pathology and clinical course.
    Herrlinger U; Felsberg J; Küker W; Bornemann A; Plasswilm L; Knobbe CB; Strik H; Wick W; Meyermann R; Dichgans J; Bamberg M; Reifenberger G; Weller M
    Ann Neurol; 2002 Oct; 52(4):390-9. PubMed ID: 12325066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BCOR-CCNB3 fusion-positive clear cell sarcoma of the kidney.
    Han H; Bertrand KC; Patel KR; Fisher KE; Roy A; Muscal JA; Venkatramani R
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28151. PubMed ID: 31876361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene of the month: BCOR.
    Aldera AP; Govender D
    J Clin Pathol; 2020 Jun; 73(6):314-317. PubMed ID: 32161069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A polyphenotypic malignant paediatric brain tumour presenting a MN1-PATZ1 fusion, no epigenetic similarities with CNS High-Grade Neuroepithelial Tumour with MN1 Alteration (CNS HGNET-MN1) and related to PATZ1-fused sarcomas.
    Burel-Vandenbos F; Pierron G; Thomas C; Reynaud S; Gregoire V; Duhil de Benaze G; Croze S; Chivoret N; Honavar M; Figarella-Branger D; Maurage CA; Pedeutour F; Hasselblatt M; Godfraind C
    Neuropathol Appl Neurobiol; 2020 Aug; 46(5):506-509. PubMed ID: 32397004
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.